Evidence map›Paper›PMID 16829538›Full record

ArticleBMJ (Clinical research ed.)2006

Whooping cough in school age children with persistent cough: prospective cohort study in primary care.

Anthony Harnden, Cameron Grant, Timothy Harrison, Rafael Perera, Angela B Brueggemann, Richard Mayon-White, David Mant

Registry-linked trialOpen access · bronzeAbstract readMulticenter Study
In one paragraph

Article in BMJ (Clinical research ed.), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01279668 (A Double Blind Randomised Placebo Controlled Trial of Montelukast in the Treatment of Acute Persistent Cough in Young People and Adults in Primary Care), which is not on this map. Cited by 35 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 5 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01279668 phase4unknown statusnot on this mapstarted 2011, after this paper: background citation

A Double Blind Randomised Placebo Controlled Trial of Montelukast in the Treatment of Acute Persistent Cough in Young People and Adults in Primary Care

TypeinterventionalSponsorUniversity of OxfordRan2011 to 2012Enrolled276ConditionsPersistent Cough, Whooping CoughArmsMontelukast, Placebo
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 5 syntheses or guidelines pooled it, 134 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Symptomatic treatment of the cough in whooping cough.The Cochrane database of systematic reviews · 2014
    Pooled it
  5. Guideline
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Retrospective cohort study investigating extent of pertussis transmission during a boarding school outbreak, England, December 2017 to June 2018.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2021
    Article
  13. Review
  14. Article
  15. Observational
  16. Article
  17. Prevention of pertussis: An unresolved problem.Human vaccines & immunotherapeutics · 2018
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Anthony HarndenDepartment of Primary Health Care, University of Oxford, Oxford OX3 7LF. anthony.harnden@dphpc.ox.ac.uk
Cameron Grant
Timothy Harrison
Rafael Perera
Angela B Brueggemann
Richard Mayon-White
David Mant
University of Oxford · GBPrimary Health Care · QAUniversity of Auckland · NZ

Funding

Medical Research Council G0000340
6 · The paper itself

Abstract

objectiveTo estimate the proportion of school age children with a persistent cough who have evidence of a recent Bordetella pertussis infection.

designProspective cohort study (October 2001 to March 2005).

settingGeneral practices in Oxfordshire, England.

participants172 children aged 5-16 years who presented to their general practitioner with a cough lasting 14 days or more who consented to have a blood test.

main outcome measuresSerological evidence of a recent Bordetella pertussis infection; symptoms at presentation; duration and severity of cough; sleep disturbance (parents and child).

results64 (37.2%, 95% confidence interval 30.0% to 44.4%) children had serological evidence of a recent Bordetella pertussis infection; 55 (85.9%) of these children had been fully immunised. At presentation, children with whooping cough were more likely than others to have whooping (odds ratio 2.85, 95% confidence interval 1.39 to 5.82), vomiting (4.35, 2.04 to 9.25), and sputum production (2.39, 1.14 to 5.02). Children with whooping cough were also more likely to still be coughing two months after the start of their illness (85% v 48%; P = 0.001), continue to have more than five coughing episodes a day (P = 0.049), and cause sleep disturbance for their parents (P = 0.003).

conclusionsFor school age children presenting to primary care with a cough lasting two weeks or more, a diagnosis of whooping cough should be considered even if the child has been immunised. Making a secure diagnosis of whooping cough may prevent inappropriate investigations and treatment.

Indexed as

AdolescentChildChild, PreschoolChronic DiseaseEnglandEnzyme-Linked Immunosorbent AssayFamily PracticeFemaleHumansImmunoglobulin GMalePertussis ToxinPrevalencePrognosisProspective StudiesSleep Wake DisordersImmunoglobulin GPertussis Toxin

Identifiers

PMID16829538
PMCPMC1513463
OpenAlexW2134867341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.